• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:未生育女性子宫癌肉瘤

Case report: Carcinosarcoma of uterus in nulliparous women.

作者信息

Sun Feiyue, Li Xuelei, Kang Luyao, Wang Yiran, Li Hongyu, Zhu Hai

机构信息

Gynecologic Oncology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Oncol. 2024 Dec 11;14:1472416. doi: 10.3389/fonc.2024.1472416. eCollection 2024.

DOI:10.3389/fonc.2024.1472416
PMID:39723383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11668669/
Abstract

BACKGROUND

Uterine carcinosarcoma (UCS), or malignant mixed Müllerian tumor, is a cancer that include both carcinomatous and sarcomatous components, resembling endometrial carcinoma. A 55-year-old woman was admitted to the hospital with postmenopausal vaginal bleeding. Gross examination of the specimen revealed brittle tissue in the fundus and the left wall of the endometrium. Postoperative pathology revealed a mixture of well-differentiated endometrioid adenocarcinoma and osteosarcoma. The patient was never given birth, which may be relevant to the diagnosis. Literature review suggests that being nulliparous may be a significant risk factor for developing uterine carcinosarcoma.

CASE DESCRIPTION

In December 2023, a 55-year-old female patient was admitted to the hospital with postmenopausal vaginal bleeding. Hysteroscopic surgery was performed, and the postoperative pathology showed endometrial cancer accompanied by ossified tissue with necrosis. The immunohistochemical results indicated positive Estrogen receptors (ER), positive Progesterone receptors (PR), ki67 positivity at 70%, negative PTEN, mutated positive p53, focal positive Pax-8, positive SATB2, positive Cytokeratin 7 (CK7), positive EMA and positive Vimentin (Vim). The patient was diagnosed with Uterine carcinosarcoma. On December 18, 2023, the patient underwent partial vaginal resection, bilateral salpingo-oophorectomy, pelvic lymph node dissection, and a sub-extensive laparoscopic hysterectomy. Postoperatively, the patients received radiotherapy and four cycles of chemotherapy in the DC regimen. As of July 2024, laboratory and impact test results showed no tumor recurrence. The patient's disease-free survival (DFS) was seven months.

CONCLUSION

The rate of childless in patients with uterine carcinosarcoma is at a high level.

摘要

背景

子宫癌肉瘤(UCS),即恶性混合性苗勒管肿瘤,是一种同时包含癌性和肉瘤性成分的癌症,类似于子宫内膜癌。一名55岁女性因绝经后阴道出血入院。标本大体检查显示子宫内膜底部和左壁组织质脆。术后病理显示为高分化子宫内膜样腺癌和骨肉瘤的混合物。该患者从未生育,这可能与诊断有关。文献综述表明未生育可能是发生子宫癌肉瘤的一个重要危险因素。

病例描述

2023年12月,一名55岁女性患者因绝经后阴道出血入院。进行了宫腔镜手术,术后病理显示子宫内膜癌伴有骨化组织及坏死。免疫组化结果显示雌激素受体(ER)阳性、孕激素受体(PR)阳性、ki67阳性率为70%、PTEN阴性、p53突变阳性、Pax - 8局灶阳性、SATB2阳性、细胞角蛋白7(CK7)阳性、上皮膜抗原(EMA)阳性和波形蛋白(Vim)阳性。该患者被诊断为子宫癌肉瘤。2023年12月18日,患者接受了部分阴道切除术、双侧输卵管卵巢切除术、盆腔淋巴结清扫术以及次广泛腹腔镜子宫切除术。术后,患者接受了放疗及DC方案的四个周期化疗。截至2024年7月,实验室及影像学检查结果显示无肿瘤复发。患者的无病生存期(DFS)为7个月。

结论

子宫癌肉瘤患者的未育率处于较高水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/8f0d3ad6607d/fonc-14-1472416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/54d787fd8344/fonc-14-1472416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/c1a777db9951/fonc-14-1472416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/8f0d3ad6607d/fonc-14-1472416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/54d787fd8344/fonc-14-1472416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/c1a777db9951/fonc-14-1472416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8697/11668669/8f0d3ad6607d/fonc-14-1472416-g003.jpg

相似文献

1
Case report: Carcinosarcoma of uterus in nulliparous women.病例报告:未生育女性子宫癌肉瘤
Front Oncol. 2024 Dec 11;14:1472416. doi: 10.3389/fonc.2024.1472416. eCollection 2024.
2
Carcinosarcoma of the uterus: A case report.子宫癌肉瘤:一例报告。
Mol Clin Oncol. 2016 Apr;4(4):571-573. doi: 10.3892/mco.2016.744. Epub 2016 Jan 27.
3
Uterine carcinosarcoma with heterologous mesenchymal element: a case report of a rare and aggressive tumor.伴有异源性间叶成分的子宫癌肉瘤:一例罕见侵袭性肿瘤的病例报告
Oxf Med Case Reports. 2024 Feb 16;2024(2):omad157. doi: 10.1093/omcr/omad157. eCollection 2024 Feb.
4
Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature.卵巢癌肉瘤癌性成分的皮肤转移:一例报告并文献复习。
Diagn Pathol. 2022 Oct 5;17(1):76. doi: 10.1186/s13000-022-01256-x.
5
[Primary uterine hepatoid adenocarcinoma: Clinicopathological analysis of 2 cases and literature review].[原发性子宫肝样腺癌:2例临床病理分析及文献复习]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Dec 18;56(6):1126-1131. doi: 10.19723/j.issn.1671-167X.2024.06.030.
6
Carcinosarcoma of the corpus uteri (Malignant Müllerian Mixed Tumor): a case report in Yaoundé (Cameroon).子宫体癌肉瘤(恶性苗勒管混合瘤):喀麦隆雅温得的一例病例报告
Pan Afr Med J. 2013 Dec 19;16:145. doi: 10.11604/pamj.2013.16.145.3497. eCollection 2013.
7
Uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.子宫绒毛膜癌合并子宫内膜腺癌:病例报告及文献复习。
BMC Womens Health. 2023 May 10;23(1):252. doi: 10.1186/s12905-023-02377-1.
8
Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.子宫癌肉瘤中癌性和肉瘤性成分的免疫组织化学分析:一例报告
Pathol Res Pract. 2008;204(3):203-7. doi: 10.1016/j.prp.2007.11.009. Epub 2008 Jan 18.
9
Unexpected rare uterine carcinosarcoma with neuroendocrine differentiation: Reflections on clinical diagnosis and treatment of a case report.意外罕见的具有神经内分泌分化的子宫癌肉瘤:对一例病例报告的临床诊断和治疗的思考。
Medicine (Baltimore). 2024 Jul 12;103(28):e38800. doi: 10.1097/MD.0000000000038800.
10
Synchronous endometrial adenocarcinoma and carcinosarcoma in endometrial polyp.子宫内膜息肉中的同步性子宫内膜腺癌和癌肉瘤
SAGE Open Med Case Rep. 2018 May 23;6:2050313X18777164. doi: 10.1177/2050313X18777164. eCollection 2018.

本文引用的文献

1
Social determinants of health in uterine carcinosarcoma.子宫癌肉瘤的健康社会决定因素。
Gynecol Oncol. 2024 May;184:117-122. doi: 10.1016/j.ygyno.2024.01.042. Epub 2024 Feb 2.
2
Clinico-Pathological Characteristics, Management, and Prognostic Factors of Patients with Uterine Carcinosarcoma: a Retrospective Analysis.子宫癌肉瘤患者的临床病理特征、治疗及预后因素:一项回顾性分析
Indian J Surg Oncol. 2023 Jun;14(2):466-472. doi: 10.1007/s13193-022-01563-1. Epub 2022 Aug 8.
3
Detecting the skewness of data from the five-number summary and its application in meta-analysis.
从五数概括中检测数据的偏度及其在荟萃分析中的应用。
Stat Methods Med Res. 2023 Jul;32(7):1338-1360. doi: 10.1177/09622802231172043. Epub 2023 May 10.
4
Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review.低收入和中等收入国家患者辅助生殖技术的财务成本:一项系统综述。
Hum Reprod Open. 2023 Mar 1;2023(2):hoad007. doi: 10.1093/hropen/hoad007. eCollection 2023.
5
Endometrial carcinosarcoma.子宫内膜癌肉瘤
Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073.
6
Beyond Serous: Treatment Options for Rare Endometrial Cancers.超越浆液性:罕见子宫内膜癌的治疗选择。
Curr Treat Options Oncol. 2022 Nov;23(11):1590-1600. doi: 10.1007/s11864-022-01014-7. Epub 2022 Oct 7.
7
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.子宫肉瘤和罕见的具有恶性潜能的子宫间叶性肿瘤。法国肉瘤集团和罕见妇科肿瘤集团的诊断指南。
Gynecol Oncol. 2022 Nov;167(2):373-389. doi: 10.1016/j.ygyno.2022.07.031. Epub 2022 Sep 14.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.子宫癌肉瘤与子宫内膜浆液性和透明细胞癌:生存的系统评价和荟萃分析。
Int J Gynaecol Obstet. 2022 Sep;158(3):520-527. doi: 10.1002/ijgo.14033. Epub 2021 Dec 11.
10
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.TCGA 分子分类在子宫癌肉瘤中的预后价值。
Int J Gynaecol Obstet. 2022 Jul;158(1):13-20. doi: 10.1002/ijgo.13937. Epub 2021 Oct 11.